Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lin, Ping"'
Autor:
Hall, Arnaldur, Maynard, Scott, Wu, Lin-Ping, Merchut-Maya, Joanna Maria, Strauss, Robert, Moghimi, Seyed Moein, Bartek, Jiri
Publikováno v:
In Journal of Controlled Release 10 September 2019 309:158-172
Autor:
Wu, Lin-Ping, Ficker, Mario, Mejlsøe, Søren L., Hall, Arnaldur, Paolucci, Valentina, Christensen, Jørn B., Trohopoulos, Panagiotis N., Moghimi, Seyed M.
Publikováno v:
In Journal of Controlled Release 28 January 2017 246:88-97
Autor:
Azmi, Intan D.M., Wibroe, Peter P., Wu, Lin-Ping, Kazem, Ali I., Amenitsch, Heinz, Moghimi, Seyed M., Yaghmur, Anan
Publikováno v:
In Journal of Controlled Release 10 October 2016 239:1-9
Autor:
Yi-Bin Liu, Xiayun Chen, Xian‐Tong Chen, Rong-Rong Zheng, Xi-Yong Yu, Hong Cheng, Chang Wang, Ling-Shan Liu, Shi-Ying Li, Lin-Ping Zhao
Publikováno v:
Journal of Controlled Release. 336:159-168
Apoptosis resistance of tumor cells often results in chemoresistance and treatment failure in clinic. In this work, a Cu2+-coordinated morusin/doxorubicin biological organizer (designated as COMBO) is designed to combat cellular resistance to apoptos
Autor:
Jiri Bartek, Arnaldur Hall, Lin-Ping Wu, Robert Strauss, Joanna Maria Merchut-Maya, Seyed Moein Moghimi, Scott Maynard
Publikováno v:
Journal of Controlled Release. 309:158-172
Acquired resistance to the oncogenic BRAFE600 inhibitor vemurafenib is a major clinical challenge in the treatment of melanoma. Vemurafenib resistance is poorly understood; however, available evidence indicates that reprogrammed mitochondrial metabol
Autor:
Peter P. Wibroe, Intan Diana Mat Azmi, Heinz Amenitsch, Lin-Ping Wu, Seyed Moein Moghimi, Ali I. Kazem, Anan Yaghmur
Publikováno v:
Journal of Controlled Release. 239:1-9
Non-lamellar liquid crystalline aqueous nanodispersions, known also as ISAsomes (internally self-assembled 'somes' or nanoparticles), are gaining increasing interest in drug solubilisation and bio-imaging, but they often exhibit poor hemocompatibilit